If clinically appropriate, treatment options may be discussed and fulfilled through licensed providers and pharmacies where permitted
While MIC injections are not a standalone weight loss cure, their lipotropic properties support a healthy metabolism
AOD-9604 is not FDA-approved, so a clinician will evaluate the reaction without label-based guidance
Individuals most likely to benefit include: Those with pernicious anemia People with gastrointestinal disorders (e.g., Crohns disease, celiac disease, chronic gastritis) Patients following bariatric (weight loss) surgery Older adults with absorption difficulties Strict vegetarians or vegans at risk for deficiency People taking medications that can decrease vitamin B12 levels Laboratory testing usually confirms B12 deficiency before starting injections
Combines fat-cell lipolysis, mitochondrial metabolic support, visceral fat reduction, and selective GH release